The Swedish stock market has been buoyant, with the pan-European STOXX Europe 600 Index reaching record highs due to slowing inflation and potential interest rate cuts by the European Central Bank. Amid this optimistic backdrop, investors are increasingly focusing on growth companies with high insider ownership, as these stocks often signify strong confidence from those closest to the business.
Top 10 Growth Companies With High Insider Ownership In Sweden
Overview: BioArctic AB (publ) develops biological drugs for central nervous system disorders in Sweden and has a market cap of SEK14.59 billion.
Operations: BioArctic AB (publ) generates revenue from its biotechnology segment, amounting to SEK299.35 million.
Insider Ownership: 34%
Revenue Growth Forecast: 42.4% p.a.
BioArctic AB, a Swedish growth company with high insider ownership, has recently shown significant progress. The company's Q2 2024 earnings revealed a substantial increase in sales to SEK 49.84 million from SEK 2.71 million year-on-year, although it reported a net loss of SEK 68.43 million. Notably, BioArctic's partner Eisai received UAE approval for Leqembi®, an Alzheimer's treatment developed collaboratively, which could enhance future revenue streams. Additionally, the promising phase-1 results for exidavnemab highlight BioArctic's innovative pipeline targeting neurodegenerative diseases like Parkinson's disease.
Overview: Humble Group AB (publ) refines, develops, and distributes fast-moving consumer products in Sweden and internationally, with a market cap of SEK5.60 billion.
Operations: The revenue segments for Humble Group AB (publ) include Future Snacking at SEK950 million, Sustainable Care at SEK2.30 billion, Quality Nutrition at SEK1.53 billion, and Nordic Distribution at SEK2.67 billion.
Insider Ownership: 13%
Revenue Growth Forecast: 11.5% p.a.
Humble Group AB, a Swedish growth company with high insider ownership, reported Q2 2024 sales of SEK 1.86 billion and net income of SEK 32 million. The six-month period saw sales rise to SEK 3.70 billion, reversing a prior net loss to achieve a net income of SEK 55 million. Recent debt financing increased credit facilities by SEK 300 million, enhancing liquidity. Insider buying has been substantial recently, signaling confidence in projected revenue growth and profitability within three years.
Overview: Vimian Group AB (publ) operates in the global animal health industry and has a market cap of SEK22.34 billion.
Operations: The company's revenue segments include Medtech (€111.91 million), Diagnostics (€20.63 million), Specialty Pharma (€158.39 million), and Veterinary Services (€53.95 million).
Insider Ownership: 11.1%
Revenue Growth Forecast: 11.9% p.a.
Vimian Group AB, with substantial recent insider buying and no significant insider selling, reported Q2 2024 sales of €90.99 million, up from €81.31 million a year ago, and net income of €4.87 million compared to €2.99 million previously. Despite shareholder dilution over the past year, Vimian's earnings are forecast to grow significantly at 62.89% annually over the next three years, outpacing the Swedish market's expected growth of 14.9%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include OM:BIOA B OM:HUMBLE and OM:VIMIAN.
